Aristeia Capital’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-727,836
Closed -$4.73K 564
2022
Q4
$4.73K Hold
727,836
﹤0.01% 489
2022
Q3
$35K Hold
727,836
﹤0.01% 503
2022
Q2
$89K Hold
727,836
﹤0.01% 438
2022
Q1
$165K Buy
+727,836
New +$170K ﹤0.01% 473

Other funds holding GLS.WS

Aristeia Capital's GLS.WS Position: Q1 2023 in Review

Aristeia Capital sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q1 2023, closing a stake of 727,836 shares — an estimated $4.73K sold.

Aristeia Capital first reported a position in GLS.WS in Q1 2022 and held it in 4 quarters. The position peaked at $165K in Q1 2022. 4 funds tracked by Wall St. Rank hold GLS.WS as of Q1 2023.

  • Aristeia Capital reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • Aristeia Capital sold 727,836 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2023, an estimated $4.73K.
  • Aristeia Capital first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
  • Aristeia Capital's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $165K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.